0 items USD 0.00Search
Your search for "delveinsight urinary tract infections pipeline insight 2018" gave back 358 results.
Examining Opportunities and future business potential for value chain players in India As India reeling under the pressure to reduce carbon emission...
Catalog:
Enincon
April 2019
Price: USD 1,299.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
"Analysing Futuristic Business Potential for Domestic & Global Players" India has limited natural gas reserves. Development of...
Catalog:
Enincon
April 2017
Price: USD 899.00
In order to track the holistic picture of current O&G to present the futuristic case for the segment in India, enincon consulting llp attempts to...
Catalog:
Enincon
October 2016
Price: USD 2,399.00
India is set to see its demand for LNG to grow atleast two times from the current levels till 2022 and might hover around 33 MMTPA. Also, the import...
Catalog:
Enincon
January 2018
Price: USD 1,499.00
Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital...
Catalog:
iGATE
July 2017
Price: USD 1,890.00
The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new...
Catalog:
iGATE
September 2016
Price: USD 1,100.00
Oil India Limited - Strategy, SWOT and Corporate Finance Report Summary Oil India Limited - Strategy, SWOT and Corporate Finance Report, is a source...
Catalog:
MarketLine
January 2023
Price: USD 175.00
The Research provides critical analysis of the key business models, strategies and developments, whilst providing insights into the future of the...
Catalog:
MRRPB3
June 2018
Price: USD 1,495.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India is on the verge to witness a major transformation not only in terms of its social stature but in economic repute too. With correct measures...
Catalog:
Enincon
November 2016
Price: USD 2,199.00
The Indian pharma industry has always been a leading industrial sector in the country, with a paralleled dominance of both domestic and foreign...
Catalog:
RNCOS
June 2022
Price: USD 900.00
Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report Summary Dr. Reddy's Laboratories Limited - Strategy, SWOT...
MarketLine
March 2022
Price: USD 175.00
BGR Energy Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary BGR Energy Systems Ltd - Strategy, SWOT and Corporate Finance Report, is...
MarketLine
December 2022
Price: USD 175.00
